amlexanox has been researched along with Body Weight in 2 studies
amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, Q | 1 |
| Xia, X | 1 |
| Yao, K | 1 |
| Zeng, J | 1 |
| Wang, W | 1 |
| Wu, Q | 1 |
| Tang, R | 1 |
| Zou, X | 1 |
| Cruz, VH | 1 |
| Arner, EN | 1 |
| Wynne, KW | 1 |
| Scherer, PE | 1 |
| Brekken, RA | 1 |
2 other studies available for amlexanox and Body Weight
| Article | Year |
|---|---|
Amlexanox reversed non-alcoholic fatty liver disease through IKKε inhibition of hepatic stellate cell.
Topics: Actins; Aminopyridines; Animals; Body Weight; Energy Metabolism; Gene Expression; Glucose; Hepatic S | 2019 |
Loss of Tbk1 kinase activity protects mice from diet-induced metabolic dysfunction.
Topics: Aminopyridines; Animals; Body Weight; Diet, High-Fat; Disease Models, Animal; Fatty Liver; I-kappa B | 2018 |